Drug intelligence / Profile preview

ropivacaine + dexamethasone (Corewell Health)

Development stage
Unknown
Lead developer
Corewell Health
Modality
Small Molecules
Administration
Percutaneous
01

Overview

Early TAP Block refers to a specific perioperative analgesic intervention developed and studied by William Beaumont Hospitals (now Corewell Health East) for managing postoperative pain in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). The intervention consists of a combination of ropivacaine, a long-acting local anesthetic, and dexamethasone, a corticosteroid used as an adjuvant to prolong the duration of the block. Ropivacaine works by inhibiting voltage-gated sodium channels in nerve fibers, thereby blocking the conduction of pain impulses. Dexamethasone is thought to enhance the block's efficacy through anti-inflammatory effects and potentially by direct action on glucocorticoid receptors in the nerves. In this specific protocol, the block is administered at the initiation of the surgical procedure (early) to provide preemptive analgesia, compared against a late administration at the conclusion of the procedure.

Other names
Early TAP BlockLaparoscopic Transversus Abdominis Plane Block
02

Targets

GR (Glucocorticoid receptor)NaV alpha (Voltage-gated sodium channel alpha subunit family)

Beyond the preview

Go deeper on ropivacaine + dexamethasone (Corewell Health).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ropivacaine + dexamethasone (Corewell Health).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call